What Researchers Did
Researchers evaluated the clinimetrics of transcutaneous oxygen (TcPO2) measurement in adults and discussed its potential applications in clinical practice.
What They Found
The evaluation of existing evidence indicated that reduced transcutaneous oxygen (TcPO2) correlates with increased skin ischemia. TcPO2 measurement demonstrated predictive value for wound healing in diabetic patients, success rates of hyperbaric oxygen therapy, and amputation rates in patients with peripheral vascular disease or ischemic ulcers.
What This Means for Canadian Patients
Transcutaneous oxygen (TcPO2) measurement could offer Canadian clinicians a non-invasive tool to assess skin ischemia and predict wound healing outcomes. This could potentially guide treatment decisions for patients with diabetes, peripheral vascular disease, or those undergoing hyperbaric oxygen therapy.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
This evaluation relies on existing evidence and does not present new primary data or clinical trial results.